Hefter: Psilocybin & End of Life Research
(Santa Fe, NM & Johns Hopkins University)

The Heffter Research Institute promotes research of the highest scientific quality with psychedelic substances in order to contribute to a greater understanding of the mind, leading to the improvement of the human condition, and the alleviation of suffering.” The Riverstyx Foundation is currently partnering with Heffter to support the John Hopkins School of Medicine research team in their assessment of psilocybin’s ability to alleviate anxiety and existential conflict in later stage cancer patients. Supported through the creation of a safe and comfortable set and setting, the researchers at John Hopkins are investigating psilocybin’s potential in occasioning an introspective and spiritually significant experience, ultimately in hopes of reducing suffering and improving quality of life for the dying.